Risk factors and outcomes of early infection in liver transplant recipients with acute-on-chronic liver failure

J Dig Dis. 2022 Nov;23(11):642-650. doi: 10.1111/1751-2980.13151.

Abstract

Objectives: Patients with acute-on-chronic liver failure (ACLF) have a high risk of infection after liver transplantation (LT). In this study, we aimed to evaluate the prevalence of early post-LT infection (within one month after LT) in recipients with ACLF, and to compare the survival rate between patients with or without post-LT infection.

Methods: Patients with ACLF who underwent LT between January 2015 and December 2017 were retrospectively included. Characteristics of the patients, prevalence, site and pathogen of post-LT infection, and its risk factors were evaluated.

Results: A total of 62 patients with ACLF developed bacterial or fungal infection after LT. The 30-day, 90-day, and 1-year survival rates in the infected group were found to be significantly lower than those in the non-infected group (67.7% vs 98.5%, 64.5% vs 97.7%, and 48.4% vs 95.4%; all P < 0.001). The most common pathogens involved were carbapenem-resistant gram-negative organisms, including Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter lwoffi. Multivariate analysis demonstrated that reoperation and length of intensive care unit stay were independently associated with post-LT infection. In addition, living donor LT and early allograft dysfunction were independently associated with 30-day all-cause mortality, whereas red blood cell transfusion and post-LT infection were independently associated with all-cause 30-day and 90-day mortality after LT.

Conclusions: Early infection after LT is a major prognostic factor in patients with ACLF. Constant vigilance for the risk factors of early infection after LT is needed for timely diagnosis and prompt intervention.

Keywords: acute-on-chronic liver failure; antibiotic prophylaxis; carbapenem-resistant organism; infections; liver transplantation.

MeSH terms

  • Acute-On-Chronic Liver Failure* / etiology
  • Carbapenems
  • Humans
  • Liver Transplantation*
  • Retrospective Studies
  • Risk Factors

Substances

  • Carbapenems